Cytek Biosciences, Inc.

CTKB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$6-$11$10
Dep. & Amort.$3$3$3$3
Deferred Tax-$3-$2-$0$0
Stock-Based Comp.$6$7$7$7
Change in WC-$4-$1$3-$6
Other Non-Cash-$1-$1-$1-$12
Operating Cash Flow-$4$0-$0$2
Investing Activities
PP&E Inv.-$1-$2-$1-$1
Net Acquisitions$0$0$0-$0
Inv. Purchases-$60-$81-$60-$107
Inv. Sales/Matur.$79$66$70$45
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$19-$16$9-$63
Financing Activities
Debt Repay.$2$1-$1$3
Stock Issued$0$1$0$0
Stock Repurch.$0-$5-$11-$7
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$1
Financing Cash Flow$2-$3-$12-$4
Forex Effect$1-$1-$1$2
Net Chg. in Cash$18-$20-$3-$64
Supplemental Information
Beg. Cash$75$95$99$162
End Cash$93$75$95$99
Free Cash Flow-$5-$1-$1$1
Cytek Biosciences, Inc. (CTKB) Financial Statements & Key Stats | AlphaPilot